Table 1.
Primary Malignancy Sites in patients Admitted to Hospital with a Diagnosis of a Secondary Adrenal Malignancy
| Primary Site (ICD10 AM codes) |
Total N N = 15,040 |
Adrenal Insufficiency N = 172* |
Adrenal Crisis N = 24 |
|---|---|---|---|
| N (%) | N (%) | N (%) | |
| Malignant neoplasms of respiratory and intrathoracic organs (C30-C39) | 7450 (49.5) | 53 (30.8) | 4 (16.7) |
| Malignant neoplasms of digestive organs (C15-C26) | 2409 (16.0) | 20 (11.6) | 0 |
| Melanoma and other malignant neoplasms of skin (C43-C44) | 1392 (9.3) | 28 (16.3) | 3 (12.5) |
| Malignant neoplasms of urinary tract (C64-C68) | 1196 (8.0) | 27 (15.7) | 2 (8.3) |
| Malignant neoplasms of ill-defined, secondary and unspecified sites (C76-C80) | 916 (6.1) | 12 (7.0) | 8 (33.3) |
| Malignant neoplasm of breast (C50) | 688 (4.6) | 18 (10.5) | 1 (4.2) |
| Malignant neoplasms of male genital organs (C60-C63) | 305 (2.0) | 4 (2.3) | 3 (12.5) |
| Malignant neoplasms of female genital organs (C51-C58) | 211 (1.4) | 1 (0.6) | 0 |
| Malignant neoplasms of mesothelial and soft tissues (C45-C49) | 112 (0.7) | 0 | 0 |
| Malignant neoplasms of lip, oral cavity and pharynx (C00-C14) | 92 (0.6) | 1 (0.6) | 1 (4.2) |
| Benign neoplasms (D10-D36) | 65 (0.4) | 3 (1.7) | 1 (4.2) |
| Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue (C81-C96) | 55 (0.4) | 0 | 0 |
|
Malignant neoplasms of thyroid and other endocrine glands (C73-C75) |
38 (0.3) | 1 (0.6) | 0 |
| Malignant neoplasms of eye, brain, and other parts of central nervous system (C69-C72) | 38 (0.3) | 0 | 0 |
| Malignant neoplasms of bone and articular cartilage (C40-C41) | 34 (0.2) | 1 (0.6) | 0 |
| Neoplasms of uncertain or unknown behaviour (D37-D48) | 31 (0.3) | 3 (1.7) | 1 (4.2) |
| In situ neoplasms (D00-D09) | 8 (0.1) | 0 | 0 |
* Total reflects more than one primary site in some patients